Drugs in Pipeline
3
Phase 3 Programs
2
Upcoming Catalysts
1
Next Catalyst
Mar 15, 2026
| Drug Name | Phase |
|---|---|
Placebo | Phase 3 |
ARD-101 | Phase 3 |
Low Dose ARD-501 | Phase 2 |
1 upcoming, 0 past
Primary completion for Placebo trial (NCT06828861) in Hyperphagia
Source